Skip to Main Content

Paper Details

Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context.
Lancet Respir Med
70
2021
Author NameAffiliation
Federico AngrimanUniversity of Toronto, Canada Institute of Health Policy, Dalla Lana School of Public Health
Bruno L FerreyroUniversity of Toronto, Canada Institute of Health Policy, Dalla Lana School of Public Health, Sinai Health System and University Health Network
Lisa BurryUniversity of Toronto, Canada Leslie Dan Faculty of Pharmacy, Canada Department of Pharmacy and Medicine
Shahid HusainUniversity Health Network, University of Toronto
Shaf KeshavjeeToronto General Hospital
Laveena MunshiUniversity of Toronto, Canada Institute of Health Policy, Dalla Lana School of Public Health, Sinai Health System and University Health Network
  • 1 - 6

Datasets